At the time of writing, Omega Therapeutics Inc [OMGA] stock is trading at $0.77, down -10.57%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The OMGA shares have gain 2.94% over the last week, with a monthly amount drifted -20.29%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Omega Therapeutics Inc [NASDAQ: OMGA] stock has seen the most recent analyst activity on November 15, 2024, when Raymond James downgraded its rating to a Mkt Perform. Previously, Raymond James started tracking the stock with Outperform rating on June 18, 2024, and set its price target to $12. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $11 on December 08, 2022. Chardan Capital Markets initiated its recommendation with a Buy and recommended $12 as its price target on September 23, 2022.
For the past year, the stock price of Omega Therapeutics Inc fluctuated between $0.74 and $5.07. Currently, Wall Street analysts expect the stock to reach $9 within the next 12 months. Omega Therapeutics Inc [NASDAQ: OMGA] shares were valued at $0.77 at the most recent close of the market. An investor can expect a potential return of 1068.83% based on the average OMGA price forecast.
Analyzing the OMGA fundamentals
According to Omega Therapeutics Inc [NASDAQ:OMGA], the company’s sales were 8.10M for trailing twelve months, which represents an 214.32% jump. Gross Profit Margin for this corporation currently stands at -0.6% with Operating Profit Margin at -9.16%, Pretax Profit Margin comes in at -9.03%, and Net Profit Margin reading is -9.03%. To continue investigating profitability, this company’s Return on Assets is posted at -0.48, Equity is -2.13 and Total Capital is -0.58. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.35.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.7162 points at the first support level, and at 0.6649 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.8626, and for the 2nd resistance point, it is at 0.9577.
Ratios To Look Out For
It is important to note that Omega Therapeutics Inc [NASDAQ:OMGA] has a current ratio of 1.61. In addition, the Quick Ratio stands at 1.61 and the Cash Ratio stands at 1.26. Considering the valuation of this stock, the price to sales ratio is 5.25, the price to book ratio is 3.67.
